Stroke is mainly characterized by a decreased supply of oxygenated blood to two primary organs of the body, either heart or brain, especially due to blocked and/or ruptured arteries. Specifically, stroke is categorized into two main types: (a) Ischemic stroke, when the blockage of the oxygenated blood is due to blood clots, and (b) Hemorrhagic stroke due to breakage of the blood vessels, further interrupting the flow of blood to the brain. In either of these events, brain cells progressively degenerate and lose their functional capacity for motion, speech, memory, mood, etc. Apart from these two, a third type of stroke is Transient Ischemic attacks, also known as the “mini-strokes”, caused due to temporary clot formations that should be considered as a warning sign for more serious indications.

Conventionally, thrombolysis is the only approved stroke treatment to restore the flow of oxygenated blood; however, the treatment is time-bound and should be offered within just a couple of hours from the onset of a stroke. Moreover, further therapy is always associated with long-term rehabilitation and recovery of lost functions. However, in recent years, regenerative medicine has opened the doors of hope for patients during the post-stroke period.

Stem Cell Treatment for Stroke: Advancells Protocol

At Advancells, we have identified the unlimited potential of stem cells isolated from different Adult Autologous sources of human bodies, including Bone Marrow, Adipose Tissue, etc. With our advanced Technical Support, Scientific Excellence and Competent Quality Management System, we are focused to provide a comprehensive, personalized therapeutic solution that is best suited for individual requirements of people undergoing stem cell treatment for stroke.

With extensive research these challenges are now comprehensible to therapeutic ventures resulting in new treatments of stroke using autologous treatment/allogenic transplant for adipose-derived mesenchymal stromal cells treatment and bone marrow stromal cells treatment.

This new insight on the treatment of stroke has helped in identifying the potential to overcome stroke with stem cells, primarily using autologous stem cell transplant in form of hematopoietic stem cell transplant or mesenchymal stromal cells treatment.